Posted in

News

UF|Research Resumption Plan – Stage 2

The University of Florida has now begun Stage 2 in the process for reengaging on-campus research activities which have been interrupted by the COVID-19 pandemic.

UF Clinical Research Resumption Plan

The UF Office of Clinical Research has published guidance for resuming clinical research projects, which applies to all UF health-related human subjects research.

Shipping of Investigational Drugs

UF Health Investigational Drug Services has developed a position statement on the issue of shipping dispensed Rx to research participants.

Help Needed From UF Units! Please Donate PPE

We are seeking available supplies of N95 masks, gloves, long-sleeve Tyvek gowns, face shields, goggles, and other personal protective equipment (PPE) for UF Health clinician needs going into the COVID-19 epidemic.

Update on COVID-19 from UF|Research

COVID-19 is a significant challenge that will continue to impact our research on campus and across the state in the weeks ahead.  Given the progression of impact on campus and across the state, please take the following actions immediately: Research activities that can be accomplished remotely should move to that…

FDA Issues COVID-19 Guidance for Conducting Clinical Trials

The U.S. Food and Drug Administration has issued guidance for industry, investigators and institutional review boards conducting clinical trials during the coronavirus (COVID-19) pandemic. For more information, see https://www.fda.gov/regulatory-information/search-fda-guidance-documents/fda-guidance-conduct-clinical-trials-medical-products-during-covid-19-pandemic.